StephenHaroldBushIIMD

Obstetrics & Gynecology • Charleston, WV

Gynecologic Oncology, Minimally Invasive / Endoscopic Surgery, Urogynecology & Pelvic Reconstructive Surgery

Gynecologic Oncologist

Join to view full profile

Dr. Bush is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bush's full profile

Already have an account?

Office
#13 Courtney Dr
Charleston, WV 25304
Phone+1 304-925-4200

Education & Training

University of South Florida MorsaniFellowship, Gynecologic Oncology, 2013 - 2016
Medical College of GeorgiaFellowship, Female Pelvic Medicine and Reconstructive Surgery, 2012 - 2013
Medical College of GeorgiaResidency, Obstetrics and Gynecology, 2008 - 2012
West Virginia University School of MedicineClass of 2008

Certifications & Licensure

WV State Medical License 2016 - 2026
FL State Medical License 2013 - 2025
GA State Medical License 2012 - 2023
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

GOG Foundation New Investigator Award GOG Foundation, 2019
APGO Excellence in Teaching Award in Medical Student Education 2018-2019
CREOG National Faculty Award for Excellence in Resident Education 2018
Administrative Chief Resident Medical College of Georgia Dept of OB/GYN, 2012
AAGL Special Resident in Laparoscopy Medical College of Georgia Dept of OB/GYN, 2012
Student Teaching Award Medical College of Georgia Dept of OB/GYN, 2011
Finalist for MCG Resident of the Year Award Medical College of Georgia, 2011
CREOG Award Medical College of Georgia Dept of OB/GYN, 2010-2012
Intern of the Year Medical College of Georgia Dept of OB/GYN, 2009
Join now to see all

Clinical Trials

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2016 Mar 28
Active, not recruiting
Phase 3
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer Start of enrollment: 2016 May 03
Active, not recruiting
Phase 2, Phase 3
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2016 Nov 14
Active, not recruiting
Phase 1, Phase 2
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2017 Jun 23
Active, not recruiting
Phase 2, Phase 3
Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer Start of enrollment: 2018 Aug 01
Suspended
Phase 3
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer Start of enrollment: 2019 Jul 16
Active, not recruiting
Phase 3
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2019 Sep 20
Recruiting
Phase 3
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer Start of enrollment: 2020 Apr 09
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

56 citations
Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma
Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross, Esther Elishaev, I. Podzielinski
Annals of Oncology. 2016-07-01
18 citations
Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
Koji Matsuo, Malcolm S. Ross, Stephen H. Bush, Mayu Yunokawa, Erin A. Blake
Gynecologic Oncology. 2017-02-01
6 citations
Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma
Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross, Esther Elishaev, Mayu Yunokawa
Annals of Surgical Oncology. 2018-07-03

Journal Articles

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma
Frederick R Ueland, Esther Elishaev, Tanja Pejovic, Todd B Sheridan, Terry Morgan, Joseph L Kelley, Malcolm S Ross, Stephen H Bush, Ardeshir Hakam, Lynda D Roman, Meri..., Annals of Surgical Oncology
Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma
Lynda D Roman, Terry Morgan, Joseph L Kelley, Todd B Sheridan, Stephen H Bush, Merieme M Klobocista, Miriam D Post, Malcolm S Ross, Frederick R Ueland, Ardeshir Hakam,..., Annals of Surgical Oncology
Extended Hysterectomy for Selected Cases of Placenta Accreta
Mitchel S. Hoffman, Valerie E Whiteman, Stephen H. Bush II, Lawrence D. Devoe, Journal of Gynecologic Surgery, 6/1/2018